Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to the Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review
Current Oncology · 2025
DOI: 10.3390/curroncol32030172 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, 2025. Verfasst von Nikole O'Neal und 4 weiteren Autor:innen. Beteiligte Einrichtung: SW Idaho Biomedical & Biosafety Center, Twin Falls, ID 83301, USA. Hauptthemen laut MEDLINE: Germ-Line Mutation, PTEN Phosphohydrolase, DNA Methylation, Hamartoma Syndrome, Multiple. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Distinct subgroups of rare brain tumors can be molecularly classified using whole genome DNA methylation profiling and next-generation sequencing. Furthermore, these tools can identify germline mutations contributing to carcinogenesis. Access to molecular testing in the clinical setting is vital for pathology laboratories to make an accurate diagnosis. One molecularly unique brain tumor requiring such tools is the papillary tumor of the pineal region (PTPR). Herein, we present a case report of a 21-year-old male presenting with macrocephaly and obstructive hydrocephalus due to the PTPR. Next-generation sequencing identified a pathogenic PTEN p.G132D mutation in the tumor and matched germline findings further identified PTEN Hamartoma Tumor Syndrome (PHTS). The case report tumor was initially misdiagnosed as ependymoma while methylation profiling classified it more specifically as a PTPR, Group B. To better understand the current status of PTPRs, we conducted a systematic review of recent cases reporting on the diagnostics, treatments, and outcomes for PTPR patients. To our knowledge, this is the first case report for PTPRs revealing an association with PHTS. Our review revealed inconsistencies in diagnostics, treatments, and outcomes for PTPR, and an underutilization of definitive molecular testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SW Idaho Biomedical & Biosafety Center, Twin Falls, ID 83301, USA.
- Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
- Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT 84108, USA.
- Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA.
- Department of Cell Biology and Physiology, College of Life Sciences, Brigham Young University, Provo, UT 84602, USA.
- Simmons Center for Cancer Research, Brigham Young University, Provo, UT 84602, USA.
ORCID-Profile: Nikole O'Neal, Jeffrey Okojie, Jared Barrott
Zitieren
APA
O'Neal, N., Goold, E., Zarei Haji Abadi, F., Okojie, J., & Barrott, J. (2025). Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to the Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review. Current Oncology. https://doi.org/10.3390/curroncol32030172
Vancouver
O'Neal N, Goold E, Zarei Haji Abadi F, Okojie J, Barrott J. Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to the Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review. Current Oncology. 2025. doi:10.3390/curroncol32030172
BibTeX
@article{ONeal2025,
author = {O'Neal, Nikole and Goold, Eric and Zarei Haji Abadi, Fatemeh and Okojie, Jeffrey and Barrott, Jared},
title = {Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to the Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32030172}
}
EUVIMED